Filter
1471
Text search:
Pharmaceutical
Assessment
Featured
140
371
Language
Document type
685
314
251
82
77
20
19
12
5
3
2
1
Countries
59
59
58
58
38
37
36
35
32
30
28
25
22
21
20
19
19
19
18
17
16
15
15
14
11
10
10
10
9
9
8
8
8
7
6
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
645
102
75
70
33
25
13
1
Toolboxes
151
132
130
88
62
47
39
37
28
27
25
24
23
23
19
19
18
11
9
8
5
5
3
1
1
Lymphatic Filariasis and Podoconiosis morbidity management and disability prevention guidelines
recommended
National Guideline
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect
...
Economic Issues, Policies and Option for Action
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
3rd edition
